Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Implementing the findings of the United Kingdom prospective
diabetes study (UKPDS) for people with type 2 diabetes in England would
cost about £100m annually. This is less than 1% of planned increases
in NHS spending. The study showed that improved control of both blood
glucose and blood pressure for people with type 2 diabetes is both
effective and cost effective. In their study this week, Gray and
colleagues (p 860) estimate that implementing the main findings of the
UKPDS for all people with diagnosed type 2 diabetes in England would
cost about £100m annually. They suggest that the national service
framework for diabetes should encourage these improved standards of
care.